Adenoviral-mediated deliver of herpes simplex virus thymidine kinase results in tumor rduction and prolonged survival in a SCID mouse model of human ovarian carcinoma

Journal of Molecular Medicine

Volumn 74, Issue 8, 1996, Pages 455-462

  Rosenfeld, M E ^a   Wang, M ^a   Siegal, G P ^a   Alvarez, R D ^a   Mikheeva, G ^a   Krasnykh, V ^a   Curiel, D T ^b  

^a UNIVERSITY OF ALABAMA AT BIRMINGHAM   (United States)

^b UNIVERSITY OF ALABAMA AT BIRMINGHAM   (United States)

Author keywords

Adenovirus; Gene therapy; Herpes simplex virus thymidine kinase; Ovarian carcinoma

Indexed keywords

GANCICLOVIR; NUCLEOSIDE ANALOG; THYMIDINE KINASE; VIRUS ENZYME; VIRUS VECTOR;

ADENOVIRUS; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CANCER CELL DESTRUCTION; CANCER SURVIVAL; CONTROLLED STUDY; DOSE RESPONSE; GENE THERAPY; HERPES SIMPLEX VIRUS; HUMAN; HUMAN CELL; MOUSE; NONHUMAN; OVARY CARCINOMA; PROGNOSIS; SCID MOUSE; VIRUS GENE; VIRUS RECOMBINANT; ANIMAL; CELL CULTURE; CELL SURVIVAL; DISEASE MODEL; DRUG EFFECT; ENZYMOLOGY; FEMALE; GENETICS; METABOLISM; MORTALITY; MOUSE MUTANT; OVARY TUMOR; PATHOLOGY;

ADENOVIRIDAE; ANIMALS; CELL SURVIVAL; DISEASE MODELS, ANIMAL; FEMALE; GANCICLOVIR; GENE THERAPY; HUMANS; MICE; MICE, SCID; OVARIAN NEOPLASMS; SIMPLEXVIRUS; THYMIDINE KINASE; TUMOR CELLS, CULTURED;

EID: 0029658585     PISSN: 09462716     EISSN: None     Source Type: Journal    
DOI: 10.1007/BF00217521     Document Type: Article

References (43)

1. Whartenby KA, Abboud CN, Marrogi AJ, Ramesh R, Freeman SM (1995) Biology of disease: the biology of cancer gene therapy. Laboratory Investigation 72:131-145
2. Moolten F (1986) Tumor chemosensitivity conferred by inserted herpes thymidine kinase genes: paradigm for a prospective cancer control strategy. Cancer Res 46:5276-5281
3. Abe A, Takeo T, Emi N, Tanimoto M, Ueda R, Yee J-K, Friedmann T, Saito H (1993) Transduction of a drug-sensitive toxic gene into human leukemia cell lines with a novel retroviral vector. Proc Soc Exp Biol Med 203:354-359
4. Mullen CA, Kilstrup M, Blaese RM (1992) Transfer of the bacterial gene for cytosine deaminase to mammalian cells confers lethal sensitivity to 5-fluorocytosine: a negative selection system. Proc Natl Acad Sci USA 89:33-37
5. Culver KW, Ram Z, Walbridge S, Ishii H, Oldfield EH, Blaese RM (1992) In vivo gene transfer with retroviral vector producer cells for treatment of experimental brain tumors. Science 256:1550-1552
6. Freeman SM, Abboud CN, Whartenby KA, Packman CH, Koeplin DS, Moolten FL, Abraham GN (1993) The "bystander effect": tumor regression when a fraction of the tumor mass is genetically modified. Cancer Res 53:5274-5283
7. Elion GB, Furman PA, Fyfe JA, DeMiranda P, Beauchamp L, Schaeffer HJ (1977) Selectivity of action of an antiherpetic agent, 9-(2-hydroxyethoxymethyl) guanine. Proc Natl Acad Sci USA 74:5716-5720
8. Furman PA, McGujirt PV, Keller PM, Fyfe JA, Elion GB (1980) Inhibition by acyclovir of cell growth and DNA synthesis of cells biochemically transformed with herpesvirus genetic information. Virology 102:420-430
9. Becker TC, Noel RJ, Coats WS, Gomez-Foix AM, Alam T, Gerard RD, Newgard CB (1994) Use of recombinant adenovirus for metabolic engineering of mammalian cells. Methods Cell Biol 43:161-189
10. Rosenfeld ME, Feng M, Michael SI, Siegal GP, Alvarez RD, Curiel DT (1995) Adenvorial-mediated delivery of the herpes simplex virus thymidine kinase gene selectively sensitizes human ovarian carcinoma cells to ganciclovir. Clinical Cancer Res 1:1571-1580
11. Feng M, Cabrera G, Deshane J, Scanlon K, Curiel D (1995) Neoplastic reversion accomplished by high efficiency adenoviral-mediated delivery of an anti-ras ribozyme. Cancer Res 55: 2024-2028
12. Yu D, Wolf JK, Scanlon M, Price JE, Hung MC (1993) Enhanced c-erbB-2/neu expression in human ovarian cancer cells correlates with more severe malignancy that can be suppressed by E1A. Cancer Res 53:891-898
13. Freeman SM, McCune C, Angel C, Abraham GN, Abboud CN (1992) Treatment of ovarian carcinoma using HSV-TK gene modified vaccine - regulatory issues. Hum Gene Ther 3: 342-349
14. Sobol RE, Scanlon KJ, editors (1995) Clinical Protocols. Cancer Gene Ther 2:225-234
15. Simon RH, Engelhardt JE, Yang Y, Zepeda M, Weber-Pendleton S, Grossman M, Wilson JM (1993) Adenovirus-mediated transfer of the CFTR gene to lung of nonhuman primates: toxicity study. Hum Gene Ther 4:771-780
16. Jaffe HA, Danel C, Longenecker G, Metzger M, Setoguchi Y, Rosenfeld MA, Gant TW, Thorgeirsson SS, Stratford-Perricaudet LD, Perricaudet M, Pavirani A, Lecocq J-P, Crystal RG (1992) Adenovirus-mediated in vivo gene transfer and expression in normal rat liver. Nature Genet 1:372-378
17. Yang Y, Raper SE, Cohn JA, Engelhardt JF, Wilson JM (1993) An approach for treating the hepatobiliary disease of cystic fibrosis by somatic gene transfer. Proc Natl Acad Sci USA 90: 4601-4605
18. Quantin B, Perricaudet LD, Tajbakhsh S, Mandel J-L (1992) Adenovirus as an expression vector in muscle cells in vivo. Proc Natl Acad Sci USA 89:2581-2584
19. Bass C, Cabrera G, Elgavish A, Robert B, Siegal GP, Anderson SC, Maneval DC, Curiel DT (1995) Recombinant adenovirus-mediated gene transfer to genito-urinary epithelium in vitro and in vivo. Cancer Gene Ther 2:97-104
20. Liu T-J, Zhang W-W, Taylor DL, Roth JA, Goepfert H, Clayman GL (1994) Growth suppression of human head and neck cancer cells by the introduction of a wild-type p53 gene via a recombinant adenovirus. Cancer Res 54:3662-3667
21. Deshane J, Siegal GP, Alvarez RD, Wang M, Feng M, Cabrera G, Liu T, Kay M, Curiel DT (1995) Targeted tumor killing via an intracellular antibody against erbB-2. J Clinic Invest 96: 2980-2989
22. Smythe WR, Hwang HC, Amin KM, Eck SL, Davidson BL, Wilson JM, Kaiser LR, Albelda SM (1994) Use of recombinant adenovirus to transfer the herpes simplex virus thymidine kinase (HSVtk) gene to thoracic neoplasms: an effective in vitro drug sensitization system. Cancer Res 54:2055-2059
23. Smythe WR, Kaiser LR, Hwang HC, Amin KM, Pilewski JM, Eck SJ, Wilson JM, Albelda SM (1994) Successful adenovirus-mediated gene transfer in an in vivo model of human malignant mesothelioma. Ann Thor Surg 57:1395-1401
24. Hwang HC, Smythe WR, Elshami AA, Kucharczuk JC, Amin KM, Williams JP, Litzky LA, Kaiser LR, Albelda SM (1995) Gene therapy using adenovirus carrying the herpes simplex-thymidine kinase gene to treat in vivo models of human malignant mesothelioma and lung cancer. Am J Respir Cell Mol Biol 13:7-16
25. Bonnekoh B, Greenhalgh DA, Bundman DS, Eckhardt JN, Longley MA, Chen S-H, Woo SLC, Roop DR (1995) Inhibition of melanoma growth by adenoviral-mediated HSV thymidine kinase gene transfer in vivo. J Invest Dermatol 104: 313-317
26. O'Malley BW, Jr, Chen S-H, Schwartz MR, Woo SLC (1995) Adenovirus-mediated gene therapy for human head and neck squamous cell cancer in a nude mouse model. Cancer Res 55: 1080-1085
27. Sobol RE, Scanlon KJ, editors (1995) Clinical Protocols. Cancer Gene Ther 2:67-74
28. Yang Y, Nunes FA, Berencsi K, Furth EE, Gšnczšl E, Wilson JM (1994) Cellular immunity to viral antigens limits E1-deleted adenoviruses for gene therapy. Proc Natl Acad Sci USA 91: 4407-4411
29. Yang Y, Trinchieri G, Wilson JM (1995) Recombinant IL-12 prevents formation of blocking IgA antibodies to recombinant adenovirus and allows repeated gene therapy to mouse lung. Nature Medicine 1:890-893
30. Wilson C, Kay MA (1995) Immunomodulation to enhance gene therapy. Nature Med 1:887-889
31. Fang B, Eisensmith RC, Wang H, Kay MA, Cross RE, Landen CN, Gordon G, Bellinger DA, Read MS, Hu PC, Brinkhous KM, Woo SLC (1995) Gene therapy for hemophilia B: host immunosuppression prolongs the therapeutic effect of adenovirus-mediated factor IX expression. Hum Gene Ther 6: 1039-1044
32. Vile RG, Hart IR (1993) Use of tissue-specific expression of the herpes simplex virus thymidine kinase gene to inhibit growth of established murine melanomas following direct intratumoral injection of DNA. Cancer Res 53:3860-3864
33. Osaki T, Tanio Y, Tachibana I, Hosoe S, Kumagai T, Kawase I, Oikawa S, Kishimoto T (1994) Gene therapy for carcinoembryonic antigen-producing human lung cancer cells by cell type-specific expression of herpes simplex virus thymidine kinase gene. Cancer Res 54:5258-5261
34. Garver RI, Goldsmith KT, Rodu B, Hu P-C, Sorscher EJ (1994) Strategy for achieving selective killing of carcinomas. Gene Ther 1:46-50
35. DiMaio JM, Clary BM, Via DF, Coveney E, Pappas TN, Lyerly HK (1994) Directed enzyme pro-drug gene therapy for pancreatic cancer in vivo. Surgery 116:205-213
36. Manome Y, Abe M, Hagen MF, Fine HA, Kufe DW (1994) Enhancer sequences of the DF3 gene regulate expression of the herpes simplex virus thymidine kinase gene and confer sensitivity of human breast cancer cells to ganciclovir. Cancer Res 54:5408-5413
37. Ido A, Nakata K, Kato Y, Nakao K, Murata K, Fujita M, Ishii N, Tamaoki T, Shiku H, Nagataki S (1995) Gene therapy for hepatoma cells using a retrovirus vector carrying herpes simplex virus thymidine kinase gene under the control of human α-fetoprotein gene promoter. Cancer Res 55:3105-3109
38. McPhaul MJ, Deslypere J-P, Allman DR, Gerard RD (1993) The adenovirus-mediated delivery of a reporter gene permits the assessment of androgen receptor function in genital skin fibroblast cultures. J Biol Chem 268:26063-26066
39. Hayashi Y, DePaoli AM, Burant CF, Refetoff S (1993) Expression of a thyroid hormone-responsive recombinant gene introduced into adult mice livers by replication-defective adenovirus can be regulated by endogenous thyroid hormone receptor. J Biol Chem 269:23872-23875
40. Varley AW, Coulthard MG, Meidell RS, Gerard RD (1995) Inflammation-induced recombinant protein expression in vivo using promoters from acute-phase protein genes Proc Natl Acad Sci USA 92:5346-5350
41. Kaneko S, Hallenbeck P, Kotani T, Nakabayashi H, McGarrity G, Tamaoki T, Anderson WF, Chiang YL (1995) Adenovirus-mediated gene therapy of hepatocellular carcinoma using cancer-specific gene expression. Cancer Res 55:5283-5287
42. Tanaka T, Kanai F, Okabe S, Yoshida Y, Wakimoto H, Hamada H, Shiratori Y, Lan K-H, Ishitobi M, Omata M (1996) Adenovirus-mediated prodrug gene therapy for carcinoembryonic antigen-producing human gastric carcinoma cells in vitro. Cancer Res 56:1341-1345
43. National Institutes of Health (1985) Guide for the care and use of laboratory animals. Bethesda, NIH publication no 85-23